3131 - 3140 of 8654 Results
Title
Year
-
OPENTitle: Pathway-specific dysregulation of striatal excitatory synapses by LRRK2 mutationsJournal Name: eLifePublisher: eLife Sciences Publications, LtdVol: 9Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.7554/elife.58997Best OA location URL: https://doi.org/10.7554/elife.58997Citation Count: 49
-
OPENTitle: Human LRRK2 G2019S mutation represses post-synaptic protein PSD95 and causes cognitive impairment in transgenic miceJournal Name: Neurobiology of Learning and MemoryPublisher: Elsevier BVVol: 142Issue #:Start Page: 182End Page: 189Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nlm.2017.05.001Citation Count: 13
- Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's Disease2020OPENTitle: Aromatic L‐Amino Acid Decarboxylase Gene Therapy Enhances Levodopa Response in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 5Start Page: 851End Page: 858Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27993Best OA location URL: https://escholarship.org/uc/item/77c4k0xvCitation Count: 38
-
OPENTitle: The AfrAbia+plus Parkinson's Disease Genomic ConsortiumJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 23Issue #: 2Start Page: 140End Page: 141Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(23)00453-2Best OA location URL: http://www.thelancet.com/article/S1474442223004532/pdfCitation Count: 4
-
OPENTitle: Autosomal Dominant Parkinson's Disease Caused by SNCA p.E46K Mutation in a Family with Russian AncestryJournal Name: Movement DisordersPublisher: WileyVol: 39Issue #: 8Start Page: 1424End Page: 1425Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29821Best OA location URL: https://doi.org/10.1002/mds.29821Citation Count: 3
-
OPENTitle: A randomized, double‐blind, placebo‐controlled trial of camicinal in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 2Start Page: 329End Page: 332Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.27259Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.27259Citation Count: 16
-
OPENTitle: Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohortJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00404-wBest OA location URL: https://escholarship.org/uc/item/83h7p6szCitation Count: 15
-
OPENTitle: Disruption of the LRRK2‐FADD Interface Using Constrained PeptidesJournal Name: Peptide SciencePublisher: WileyVol: 116Issue #: 6Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/pep2.24374Best OA location URL: https://doi.org/10.1002/pep2.24374Citation Count: 0
-
OPENTitle: OnabotulinumtoxinA and cognitive behavioral therapy in functional dystonia: A pilot randomized clinical trialJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 63Issue #:Start Page: 174End Page: 178Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.009Best OA location URL: https://zenodo.org/record/3832127Citation Count: 17
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 10